Tocilizumab for the treatment of refractory pediatric mixed connective tissue disease (MCTD), in two patients
Citation:
Pediatric Rheumatology
2014
12(Suppl 1):P303
Volume 12 Supplement 1
The publication charges for this supplement were funded by the PReS 2014 congress.
21st European Pediatric Rheumatology (PReS) Congress. Go to conference site.
Belgrade, Serbia17-21 September 2014
Page 8 of 9
2022 Citation Impact
2.5 - 2-year Impact Factor
3.0 - 5-year Impact Factor
1.035 - SNIP (Source Normalized Impact per Paper)
0.732 - SJR (SCImago Journal Rank)
2023 Speed
18 days submission to first editorial decision for all manuscripts (Median)
94 days submission to accept (Median)
2023 Usage
1,095,144 downloads
691 Altmetric mentions